Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Carlyle (CG) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Carlyle (CG) over the last 15 years, with Q2 2025 value amounting to $100000.0.

  • Carlyle's Other Non Operating Income fell 6666.67% to $100000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $200000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $300000.0 for FY2024, which is 25000.0% up from last year.
  • Latest data reveals that Carlyle reported Other Non Operating Income of $100000.0 as of Q2 2025, which was down 6666.67% from $100000.0 recorded in Q4 2024.
  • Over the past 5 years, Carlyle's Other Non Operating Income peaked at $3.1 million during Q2 2021, and registered a low of -$3.5 million during Q3 2021.
  • Moreover, its 5-year median value for Other Non Operating Income was -$200000.0 (2022), whereas its average is -$153333.3.
  • Examining YoY changes over the last 5 years, Carlyle's Other Non Operating Income showed a top increase of 72000.0% in 2021 and a maximum decrease of 48333.33% in 2021.
  • Over the past 5 years, Carlyle's Other Non Operating Income (Quarter) stood at -$500000.0 in 2021, then skyrocketed by 60.0% to -$200000.0 in 2022, then skyrocketed by 50.0% to -$100000.0 in 2023, then surged by 200.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Its Other Non Operating Income stands at $100000.0 for Q2 2025, versus $100000.0 for Q4 2024 and $100000.0 for Q3 2024.